Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
Journal of Pediatric Hematology/Oncology
|
December 3, 2011
Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?
Franziska Walter, Johannes Czernin, Theodore Hall, et al.
EJNMMI Physics
|
October 27, 2015
On transcending the impasse of respiratory motion correction applications in routine clinical imaging - a consideration of a fully automated data driven motion control framework
Adam L Kesner, Paul J Schleyer, Florian Büther, et al.
Pediatric Hematology and Oncology
|
September 23, 2011
18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients
Franziska Walter, Noah Federman, Wipapat Apichairuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2007
Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial
Fabienne Iten, Beat Müller, Christian Schindler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 21, 2015
Towards tailored radiopeptide therapy
Piotr Radojewski, Rebecca Dumont, Nicolas Marincek, et al.
The Prostate
|
November 1, 2014
18F-RB390: innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET)
Reto Bertolini, Christine Goepfert, Thomas Andrieu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 2, 2016
Reply: Somatostatin Receptor-Targeted Radiopeptide Therapy in Patients with Progressive Unresectable Meningioma
Piotr Radojewski, Rebecca A Dumont, Nicolas Marincek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 17, 2015
Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial
Nicolas Marincek, Piotr Radojewski, Rebecca A Dumont, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 30, 2008
Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours
Stephan Good, Martin A Walter, Beatrice Waser, et al.
Biomaterials
|
May 21, 2014
Indium-111 labeled gold nanoparticles for in-vivo molecular targeting
Quinn K T Ng, Cristina I Olariu, Marcus Yaffee, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
Journal of Pediatric Hematology/Oncology
|
December 3, 2011
Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?
Franziska Walter, Johannes Czernin, Theodore Hall, et al.
EJNMMI Physics
|
October 27, 2015
On transcending the impasse of respiratory motion correction applications in routine clinical imaging - a consideration of a fully automated data driven motion control framework
Adam L Kesner, Paul J Schleyer, Florian Büther, et al.
Pediatric Hematology and Oncology
|
September 23, 2011
18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients
Franziska Walter, Noah Federman, Wipapat Apichairuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2007
Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial
Fabienne Iten, Beat Müller, Christian Schindler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 21, 2015
Towards tailored radiopeptide therapy
Piotr Radojewski, Rebecca Dumont, Nicolas Marincek, et al.
The Prostate
|
November 1, 2014
18F-RB390: innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET)
Reto Bertolini, Christine Goepfert, Thomas Andrieu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 2, 2016
Reply: Somatostatin Receptor-Targeted Radiopeptide Therapy in Patients with Progressive Unresectable Meningioma
Piotr Radojewski, Rebecca A Dumont, Nicolas Marincek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 17, 2015
Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial
Nicolas Marincek, Piotr Radojewski, Rebecca A Dumont, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 30, 2008
Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours
Stephan Good, Martin A Walter, Beatrice Waser, et al.
Biomaterials
|
May 21, 2014
Indium-111 labeled gold nanoparticles for in-vivo molecular targeting
Quinn K T Ng, Cristina I Olariu, Marcus Yaffee, et al.
Page
of 8